From the lab to the bench, scaling up regulatory T cell therapy

Dr Megan Levings is a Professor in the Department of Surgery and School of Biomedical Engineering at the University of British Columbia and BC Children’s Hospital Research Institute. Her laboratory studies how a special kind of white blood cell, known as a T regulatory cell, could be used as a cellular therapy to stop harmful immune responses. She is internationally recognized in the field of human immunology and leads a vibrant group of trainees and staff who are researching how to use T regulatory cells to replace conventional immunosuppression in the context of transplantation and autoimmunity. She is President Elect of the Federation of Clinical Immunology Societies and has won numerous awards, including the 2020 YWCA Woman of Distinction, Science, Research & Technology, 2022 Simon Fraser University Outstanding Alumni award, and 2022 UBC Faculty of Medicine Distinguished Researcher in the Basic/Foundational Science Category.

Hany Meås is an R&D Staff Scientist at Thermo Fisher Scientific and the project lead for the CTS™ Detachable Dynabeads™ and the CTS™ DynaCellect™ Magnetic Separation System. Hany obtained a Bachelor’s degree in Molecular Biology from the University of Sheffield, UK, and a Master’s and PhD in Molecular Medicine from the Norwegian University of Science and Technology, Norway.